FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA Compliance for Peptide Therapy and BPC 157 Holt Law An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York